Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anti-inflammatory eye drops after selective laser trabeculoplasty for glaucoma
RBR-4ttd9ycNot yet recruiting
- Sponsor
- Hospital Oftalmológico de Brasília
- Start
- May 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of prednisolone and nepafenac in open-angle glaucoma (OAG), ocular hypertension, Glaucoma and 2 more (4 arms), sponsored by Hospital Oftalmológico de Brasília. Planned start May 2022; status: not yet recruiting.
02
Drugs
prednisolonenepafenac
03
Conditions
open-angle glaucoma (OAG)ocular hypertensionGlaucomapigmentary glaucoma (PG)pigment dispersion syndrome (PDS)
Beyond the preview
Go deeper on RBR-4ttd9yc.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-4ttd9yc.